Display Settings:

Format

Send to:

Choose Destination
    Science. 2006 Dec 22;314(5807):1936-8.

    Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling.

    Source

    Department of Immunology, The Scripps Research Institute, La Jolla, CA 92037 USA.

    Abstract

    Innate immune signals mediated by Toll-like receptors (TLRs) have been thought to contribute considerably to the antibody-enhancing effects of vaccine adjuvants. However, we report here that mice deficient in the critical signaling components for TLR mount robust antibody responses to T cell-dependent antigen given in four typical adjuvants: alum, Freund's complete adjuvant, Freund's incomplete adjuvant, and monophosphoryl-lipid A/trehalose dicorynomycolate adjuvant. We conclude that TLR signaling does not account for the action of classical adjuvants and does not fully explain the action of a strong adjuvant containing a TLR ligand. This may have important implications in the use and development of vaccine adjuvants.

    PMID:
    17185603
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC1868398
    Free PMC Article

    Images from this publication.See all images (3) Free text

    Figure 1
    Figure 3
    Figure 2

      Supplemental Content

      Icon for HighWire Press Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk